Results 191 to 200 of about 522,058 (284)

How and why pharmaceutical reforms contribute to universal health coverage through improving equitable access to medicines: a case of Ghana. [PDF]

Front Public Health, 2023
Koduah A.
europepmc   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration. [PDF]

Mov Disord Clin Pract
Fothergill-Misbah N, Hooker J, Kwasa J, Walker R.   +3 more
europepmc   +1 more source

Improving access to medicines: lessons from 10 years of drug reforms in China, 2009-2020. [PDF]

BMJ Glob Health, 2022
Mao W, Jiang H, Mossialos E, Chen W.
europepmc   +1 more source

Access to Medicines Index: Measuring How Well Countries Provide Access to Medicines [PDF]

Value in Health, 2013
Shankar, R., Hickson, S., Gorokhovich, L.   +2 more
openaire   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Access to medicines, the Unified Health System, and intersectional injustices. [PDF]

Rev Saude Publica
Mujica EMM, Bastos JL, Boing AC.
europepmc   +1 more source

Antibiotic geographies and access to medicines: Tracing the role of India's pharmaceutical industry in global trade. [PDF]

Soc Sci Med, 2022
Bjerke L.
europepmc   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

The UK's Early Access to Medicines Scheme 10 years on: an evaluation using publicly available data. [PDF]

JRSM Open
Pound P, Ram R, Archibald K.
europepmc   +1 more source